ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 7015 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 LEFLUNOMIDE 6127
1 METHOTREXATE SODIUM 6113
2 ADALIMUMAB 5985
3 TOCILIZUMAB 5915
4 METHOTREXATE 5824
5 RITUXIMAB 5755
6 INFLIXIMAB 5687
7 PREDNISONE 5618
8 SULFASALAZINE 5597
9 CERTOLIZUMAB PEGOL 5583
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAFFEINE CITRATE 917 0.4058
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 237 0.3703
2 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 102 0.3389
3 PSEUDOEPHEDRINE HCL 3575 0.3264
4 CORTISONE ACETATE 3897 0.3175
5 DESOXIMETASONE 5430 0.2867
6 TRIPROLIDINE HYDROCHLORIDE 42 0.2320
7 HYDROCORTISONE BUTYRATE 412 0.2157
8 DICLOFENAC POTASSIUM TABLETS 1727 0.2063
9 USTEKINUMAB-AEKN 1 0.2000
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 6127 0.0585
1 Endoglycosidase [EPC] 233 0.0493
2 Interleukin-6 Receptor Antagonist [EPC] 6031 0.0446
3 Aminosalicylate [EPC] 5644 0.0428
4 Selective T Cell Costimulation Modulator [EPC] 5434 0.0395
5 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 718 0.0369
6 Interleukin-12 Antagonist [EPC] 3572 0.0349
7 Histamine-1 Receptor Antagonist [EPC] 2651 0.0321
8 Vitamin D [EPC] 5562 0.0186
9 CD20-directed Cytolytic Antibody [EPC] 5793 0.0176
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE